1. Home
  2. ARCB vs RLAY Comparison

ARCB vs RLAY Comparison

Compare ARCB & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ArcBest Corporation

ARCB

ArcBest Corporation

HOLD

Current Price

$76.30

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.01

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCB
RLAY
Founded
1923
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ARCB
RLAY
Price
$76.30
$8.01
Analyst Decision
Buy
Strong Buy
Analyst Count
11
7
Target Price
$90.91
$16.00
AVG Volume (30 Days)
357.9K
2.1M
Earning Date
01-30-2026
11-06-2025
Dividend Yield
0.63%
N/A
EPS Growth
N/A
N/A
EPS
4.20
N/A
Revenue
$4,039,115,000.00
$8,355,000.00
Revenue This Year
N/A
$20.47
Revenue Next Year
$3.87
N/A
P/E Ratio
$18.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$55.19
$1.78
52 Week High
$111.80
$8.70

Technical Indicators

Market Signals
Indicator
ARCB
RLAY
Relative Strength Index (RSI) 68.92 63.19
Support Level $68.75 $7.42
Resistance Level $77.93 $8.00
Average True Range (ATR) 2.78 0.52
MACD 1.56 -0.00
Stochastic Oscillator 91.81 65.26

Price Performance

Historical Comparison
ARCB
RLAY

About ARCB ArcBest Corporation

ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: